We were also reassured by the absence of any signal for increased hospitalization or surgery, which are common concerns with medications that affect gastrointestinal function. If future studies confirm these results, he added, they could reassure clinicians that GLP-1 receptor agonists can be used safely in certain patients with Crohns disease who also have obesity or diabetes
More people are exploring how semaglutide and testosterone might work together to support weight loss and hormone health
Moisture should be carefully managed to preserve texture, prevent microbial growth, and protect active ingredient potency over the products intended shelf life
If you are planning pregnancy, discuss stopping the medication with your healthcare provider in advance
Many tirzepatide users report that dinner is the hardest meal to eat
GLP-1 analogues market is witnessing rapid growth as the nation's high obesity prevalence and increased emphasis on weight loss drive demand for obesity treatment in addition to diabetes management
